SCHEMBL8716660

SCHEMBL8716660

CN1C=C(C(=O)O)c2ccccc2C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
ALOX15 P16050 3/20 0.43
TSHR P16473 2/20 0.43
SIRT1 Q96EB6 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
KMT2A Q03164 2/20 0.39
NOTUM Q6P988 1/20 0.39
SMN1; SMN2 Q16637 7/20 0.39
HTT P42858 2/20 0.39
ALDH1A1 P00352 1/20 0.39
XIAP P98170 1/20 0.39
HKDC1 Q2TB90 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
LMNA P02545 2/20 0.39
TP53 P04637 2/20 0.38
MEN1 O00255 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9332312 0.85 KDM4E (0.39) KDM4EALOX15TSHRSIRT1L3MBTL1
SCHEMBL2677144 0.78 SMN1; SMN2 (0.45) KDM4EALOX15TSHRSIRT1L3MBTL1
SCHEMBL2149851 0.76 MEN1 (0.41) KDM4EL3MBTL1KMT2AHTTALDH1A1
SCHEMBL14067662 0.76 SMN1; SMN2 (0.44) KDM4ETSHRL3MBTL1KMT2ASMN1; SMN2
SCHEMBL2676981 0.75 ALDH1A1 (0.42) KDM4EALOX15TSHRSIRT1KMT2A
SCHEMBL2149770 0.74 THRB (0.40) KDM4EALOX15TSHRSIRT1L3MBTL1
SCHEMBL9332389 0.74 KMT2A (0.39) KDM4EALOX15TSHRSIRT1KMT2A
SCHEMBL2676919 0.72 GAA (0.44) ALOX15L3MBTL1KMT2ANOTUMSMN1; SMN2
SCHEMBL29848737 0.71 NPC1 (0.42) KDM4EALOX15TSHRSIRT1KMT2A
SCHEMBL4436383 0.71 KMT2A (0.39) KDM4ETSHRKMT2ASMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5726200-A Pro-drugs for CCK antagonists WARNER-LAMBERT COMPANY (US) 1998-03-10 US disclosed
US-5554643-A Pro-drugs for CCK antagonists WARNER-LAMBERT COMPANY (US) 1996-09-10 US disclosed
US-5340825-A Pro drugs for CCK antagonists WARNER-LAMBERT COMPANY (US) 1994-08-23 US disclosed
EP-0546108-A4 PRO-DRUGS FOR CCK ANTAGONISTS 1993-09-22 EP disclosed
EP-0546108-A1 PRO-DRUGS FOR CCK ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1993-06-16 EP disclosed
WO-1992004038-A1 PRO-DRUGS FOR CCK ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1992-03-19 WO disclosed